Prevalence of apoptosis and inner cell allocation in bovine embryos cultured under different oxygen tensions with or without cysteine addition.
Supraphysiological oxygen tension during embryo culture can generate reactive oxygen species (ROS), which can induce apoptosis. Antioxidants such as thiol compounds (cysteine, cysteamine) can be used to prevent ROS damage to the embryo. The purpose of this study was to evaluate the prevalence of apoptosis during bovine embryo development and to evaluate the effect of the presence or absence of cysteine 0.6 mM in modified synthetic oviduct fluid (mSOF) on in vitro produced cattle embryos cultured under two different oxygen tensions (5% O2 versus 20% O2). Effects were assessed by checking embryo development at Days 7, 8 and 9 and by evaluating Day 9 hatched blastocysts for differentiation by means of differential staining and for apoptosis by means of TUNEL-assay. Apoptotic cells were present in 94% of Day 7 blastocysts and in 100% of Days 8 and 9 blastocysts. Cysteine addition affected Day 8 blastocyst rates in a negative way (P < 0.05) regardless of the oxygen tension. In fact, cysteine addition to the mSOF culture medium had a negative effect upon embryo development in terms of blastocyst rates, hatching rates and apoptotic cell ratio. Embryos cultured under 5% O2 in the presence of cysteine, however, possessed significantly higher numbers of ICM cells. This finding corroborates the theoretical assumption that antioxidants are beneficial for ICM development.
Van Soom
A
A
Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. ann.vansoom@rug.ac.be
Yuan
Y Q
YQ
Peelman
L J
LJ
de Matos
D G
DG
Dewulf
J
J
Laevens
H
H
de Kruif
A
A
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D017209:Apoptosis; D001755:Blastocyst / Q000166:cytology*; D001826:Body Fluids; D002417:Cattle / Q000196:embryology*; D003470:Culture Media; D046508:Culture Techniques; D003545:Cysteine / Q000008:administration & dosage*; D005314:Embryonic and Fetal Development; D005187:Fallopian Tubes; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary; D020287:In Situ Nick-End Labeling; D010100:Oxygen / Q000008:administration & dosage*; D017382:Reactive Oxygen Species / Q000378:metabolism
D000975:Antioxidants; D003470:Culture Media; D017382:Reactive Oxygen Species; D003545:Cysteine; D010100:Oxygen